I am a nuclear medicine physician with expertise in molecular imaging and targeted radionuclide therapy — particularly in the use of positron emission tomography (PET) in oncology. In addition to my role as Chief of the Molecular Imaging and Therapy Service, I also serve as Director of the Laurent and Alberta Gerschel Positron Emission Tomography Center at Memorial Sloan Kettering.
As a translational researcher and designer of clinical studies, I have focused on monitoring how tumors respond to therapy and developing radiotracers for targeted imaging and therapy. I am the author or co-author of more than 100 peer-reviewed publications that have appeared in such prestigious journals as Journal of Clinical Oncology and Proceedings of the National Academy of Sciences, and have served on the editorial boards of several scientific journals. I also serve as a mentor for graduate students, postdoctoral researchers, and physician-scientists.
- Clinical Expertise: Nuclear Medicine; Molecular Imaging and Targeted Radionuclide Therapy; PET
- Languages Spoken: English
- Education: MD, Technical University of Munich (Germany)
- Residencies: Technical University of Munich
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Led by Wolfgang A. Weber
Clinical Trials Co-Investigated by Wolfgang A. Weber
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more